Trxade Group, Inc. announced that at the annual meeting held on August 22, 2016, Fernando V. Sanchez, who had served on the board of directors, the Chairman of the Audit Committee, and the Chairman of the Audit Committee of since March 17, 2015, ended his term on the Board on those committees, as he did not stand for re-election for personal reasons. At the annual meeting, Mr. Michael L. Peterson was nominated and elected to the hold the seat held by Mr. Sanchez. Mr. Peterson was further elected as the Chairman of the Audit Committee and the Compensation Committee of the board of directors of the company. Mr. Peterson currently serves as the President and CEO of Pedevco Corp. (PED). Mr. Peterson assumed the role of CEO in May 2016 after having served as CFO between July 2012 and May 2016. With this addition, the company's board of directors now comprises four directors; two of whom are independent directors.
TRxADE Health, Inc. provides a technology-enabled health services platform. The Company is focused on digitalizing the retail pharmacy and health services experience by optimizing drug procurement, the prescription journey, access to physicians in the patientâs home and patient engagement in the United States. The Companyâs segments include Trxade, Inc., Integra Pharma Solutions, LLC (IPS) and Superlatus. Trxade, Inc. segment provides a web-based pharmaceutical marketplace platform-business to business (B2B) sales. IPS is a licensed pharmaceutical wholesaler and sells brand, generic and non-drug products to customers. The Superlatus segment holds Sapientiaâs intellectual property for advanced food extrusion technology and The Urgent Company, which is a manufacturer of ice cream that is animal product-free, vegan, lactose-free, and made with plant-B2B sales. Its subsidiaries include Community Specialty Pharmacy, LLC, Alliance Pharma Solutions, LLC, Bonum Health, LLC and others.
TRXADE HEALTH, INC. 
